The activation of the GnRHR would, in turn, induce an increase in the synthesis of estrogen in the ovary by the hypothalamic–pituitary–gonadal axis and based on estrogen’s association with osteoporosis [15,16], we initiated a study on the potential of GV1001 as a treatment for osteoporosis. The gene discussed is GNRHR; the disease is osteoporosis.